Detalhe da pesquisa
1.
Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.
Br J Haematol
; 204(3): 887-891, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38054558
2.
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.
Haematologica
; 109(3): 906-914, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37646658
3.
The role of surface molecule CD229 in Multiple Myeloma.
Clin Immunol
; 204: 69-73, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30326256
4.
Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience.
Am J Hematol
; 97(12): E451-E453, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36097868
5.
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
Am J Hematol
; 97(7): E276-E280, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35472167
6.
Current Strategies for the Immunotherapy of Multiple Myeloma.
Oncology (Williston Park)
; 31(1): 55-63, 2017 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28090624
7.
Chimeric Antigen Receptor (CAR) therapy for multiple myeloma.
Br J Haematol
; 172(5): 685-98, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26791002
8.
Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 21(1): 30-8, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25445642
9.
Restricting CAR T Cell Trafficking Expands Targetable Antigen Space.
bioRxiv
; 2024 Feb 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38370665
10.
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma.
Bone Marrow Transplant
; 59(5): 647-652, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38361116
11.
Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity.
Sci Transl Med
; 15(705): eadd7900, 2023 07 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37467316
12.
The Prolyl Hydroxylase Inhibitor Dimethyl Oxalyl Glycine Decreases Early Gastrointestinal GVHD in Experimental Allogeneic Hematopoietic Cell Transplantation.
Transplantation
; 104(12): 2507-2515, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32639407
13.
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide.
Nat Commun
; 11(1): 798, 2020 02 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32034142
14.
A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma.
Cell Transplant
; 28(12): 1624-1631, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31619057
15.
Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study.
Bone Marrow Transplant
; 59(1): 121-124, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37803198
16.
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study.
Blood Cancer J
; 14(1): 36, 2024 Mar 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38443341
17.
Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy.
Bone Marrow Transplant
; 58(4): 443-445, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36550200
18.
Novel anti-myeloma immunotherapies targeting the SLAM family of receptors.
Oncoimmunology
; 6(5): e1308618, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28638731
19.
Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation.
Oncotarget
; 8(30): 49253-49263, 2017 Jul 25.
Artigo
Inglês
| MEDLINE | ID: mdl-28512269
20.
Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma.
Blood Adv
; 6(8): 2466-2470, 2022 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34933344